Physician profile
Weining Hu
NPI 1679564728
$294.55
in general payments reported to CMS, 2019-2025
13 companies · $89.77 in 2025
The $89.77 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.04 · 2022: $59.61 · 2023: $42.69 · 2024: $57.44 · 2025: $89.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $43.81 | 2025 | Cologuard Collection Kit |
| Corium, LLC | $37.72 | 2024 | Azstarys |
| Glaxosmithkline, LLC. | $29.82 | 2021-2023 | Shingrix, Arexvy |
| Ultragenyx Pharmaceutical INC. | $29.29 | 2021-2023 | |
| Abbott Laboratories | $24.30 | 2025 | Freestyle Libre 3 |
| Biomerieux INC | $21.66 | 2025 | |
| Seqirus USA INC | $19.72 | 2024 | Fluad, Flucelvax |
| Exeltis, USA INC. | $18.21 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.30 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.52 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.10 | 2023 | |
| Organon LLC | $12.73 | 2022 | |
| Pfizer INC. | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weining Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.